The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

A Phase 3 trial of an at-home subcutaneous Briumvi injection for relapsing multiple sclerosis is complete. The new formulation aims to offer a more convenient treatment option for people with multiple ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The most common therapy, again, is ...

All prespecified end points were met with amlitelimab, demonstrating significantly higher efficacy over placebo. HealthDay News — Amlitelimab, a fully human non-T cell depleting monoclonal antibody ...

Eight deaths linked to the administration of vitamin IV infusions in Hermosillo, Sonora, Mexico have now been confirmed, along with three additional people affected—one hospitalized and two discharged ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024. In this segment, Dr. Morrison introduces the concept of ...

Since acquiring rare disease specialist Horizon Therapeutics in 2023 for $27.8 billion, Amgen has had difficulty boosting sales for the top product gained in the buyout, thyroid eye disease (TED) ...